Taking time to appreciate the industry's greatest achievements will inspire growth ahead.
Outsourcing
Latest News
Advertisement
Pharmaceutical Outsourcing Present and Future
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
Navigating the Preclinical CRO Outsourcing Process
The need for preclinical testing expertise is growing as molecular complexity increases.
A Closer Look at Affinity Ligands
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
Advertisement
Companies roll out expansions in manufacturing high-potency APIs and finished products.
Sponsor companies' increasing focus on strategic outsourcing has changed the rules of the game.
Presidents of leading associations offer views on the industry's future.
Industry wants more innovation, but can suppliers meet customer needs?
Highlights included the latest in pharmaceutical packaging equipment, containers, and labels and new capabilities among contract service providers.
Clinical research organizations see reform in clinical-trial process, including the establishment of chief innovation officer at FDA.
Recovery audits and other past practices in procurement can improve the bottom line.
Apple's experience with manufacturing facilities in China present opportunity for future best practice.
Service providers must focus on delivering a superior customer experience.
Poland's government aims to make the Eastern European country a biotech powerhouse.
Readers share their views on bioprocessing challenges, equipment use, and outsourcing trends in our annual bioprocessing equipment and processing survey.
Collaboration can begin with a conversation.
Recovery audits and other past practices in procurement can improve the bottom line.
Contract API manufacturers and fine-chemical producers roll out capacity and service expansions.
A Q&A with Erik van den Berg, CEO of AM-Pharma, on recent industry trends.
China's drug-distribution network has been a mess for years, but government reforms and industry focus are unveiling new opportunities for market order and growth.
Brazil's generic-drug market is growing steadily.
The evolving bio/pharmaceutical business model poses risk for CMOs.
More collaboration and expanded oversight aim to compel manufacturers to follow GMPs.
Pharma announces plans for the year ahead at annual JPMorgan Global Healthcare conference.
As biopharmaceutical development and commercialization increases, companies are expanding their cold-chain capabilities.
Industry optimism is on the rise for 2012.
The Asian nation is strategizing to take the lead over its regional competitors in pharmaceutical exports.
A technical forum featuring Catalent Pharma Solutions, SAFC, and Neuland Laboratories.
Advertisement
Advertisement
